A comparison of the renal function biomarkers serum creatinine, pro-enkephalin and cystatin C to predict clearance of pemetrexed von de Rouw, N., Beunders, R., Hartmann, O., Schulte, J., Boosman, R. J., Derijks, H. J., Burger, D. M., van den Heuvel, M. M., Hilbrands, L. B., Pickkers, P., ter Heine, R.

Volltext

The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study von van der Stelt, C. A. K., Vermeulen Windsant-van den Tweel, A. M. A., Egberts, A. C. G., van den Bemt, P. M. L. A., Leendertse, A. J., Hermens, W. A. J. J., van Marum, R. J., Derijks, H. J.

Volltext

Cumulative pemetrexed dose increases the risk of nephrotoxicity von de Rouw, N., Boosman, R.J., van de Bruinhorst, H., Biesma, B., van den Heuvel, M.M., Burger, D.M., Hilbrands, L.B., ter Heine, R., Derijks, H.J.

Volltext

Pharmacokinetically-guided dosing of pemetrexed in a patient with renal impairment and a patient requiring hemodialysis von de Rouw, N., Croes, S., Posthuma, R., Agterhuis, D.E., Schoenmaekers, J.J.A.O., Derijks, H.J, Burger, D.M., Dingemans, A.M., ter Heine, R.

Volltext

Influence of antidepressants on glycaemic control in patients with diabetes mellitus von Knol, M. J., Derijks, H. J., Geerlings, M. I., Heerdink, E. R., Souverein, P. C., Gorter, K. J., Grobbee, D. E., Egberts, A. C. G.

Volltext

Limited adherence to safety instructions in drug leaflets von Derijks, H. J., de Koning, G. H. P., Mantel‐Teeuwisse, A. K., Egberts, A. C. G.

Volltext

Medicatiescreening met Beers-criteria en STOPP/START-criteria bij de oudere patiënt: Associatie tussen potentieel ongewenst geneesmiddelengebruik en geneesmiddelgerelateerde zieken... von Van Der Stelt, C. A K, Vermeulen Windsant-Van Den Tweel, A. M A, Egberts, A. C G, Van Den Bemt, P. M L A, Leendertse, A. J, Hermens, W. A J T, Van Marum, R. J, Derijks, H. J

Volltext

The Association between Antidepressant Use and Disturbances in Glucose Homeostasis: Evidence from Spontaneous Reports von Derijks, H J, Meyboom, R HB, Heerdink, E R, De Koning, G HP, Janknegt, R, C.G.Egberts, A

Volltext

Impaired glucose homeostasis after imipramine intake in a diabetic patient von Derijks, Hieronymus J, De Koning, Fred H P, Meyboom, Ronald H, Heerdink, Eibert R, Spooren, Pieter F M J, Egberts, Antoine C G

Volltext

Adoption of antithrombotic stewardship and utilization of clinical decision support systems-A questionnaire-based survey in Dutch hospitals von Graafsma, Jetske, Klopotowska, Joanna E, Derijks, Hieronymus J, van de Garde, Ewoudt M W, Hoge, Rien H L, Kruip, Marieke J H A, Meijer, Karina, Karapinar-Carkit, Fatma, van den Bemt, Patricia M L A

Volltext

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment-TUMMY Study von Sivridaş, Merve, Creemers, Rob H, Wong, Dennis R, Boekema, Paul J, Römkens, Tessa E H, Gilissen, Lennard P L, van Bodegraven, Adriaan A, Loeff, Floris C, Rispens, Theo, Derijks, Luc J J

Volltext

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease von Coenen, Marieke J.H, de Jong, Dirk J, van Marrewijk, Corine J, Derijks, Luc J.J, Vermeulen, Sita H, Wong, Dennis R, Klungel, Olaf H, Verbeek, Andre L.M, Hooymans, Piet M, Peters, Wilbert H.M, te Morsche, Rene H.M, Newman, William G, Scheffer, Hans, Guchelaar, Henk-Jan, Franke, Barbara

Volltext

Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12‐month multicentre observational prospective cohort study von Schmitz, E. M. H., Boekema, P. J., Straathof, J. W. A., Renswouw, D. C., Brunsveld, L., Scharnhorst, V., Poll, M. E. C., Broeren, M. A. C., Derijks, L. J. J.

Volltext

Risk factors for thiopurine‐induced myelosuppression and infections in inflammatory bowel disease patients with a normal TPMT genotype von Broekman, M. M. T. J., Coenen, M. J. H., Wanten, G. J., van Marrewijk, C. J., Klungel, O. H., Verbeek, A. L. M., Hooymans, P. M., Guchelaar, H.‐J., Scheffer, H., Derijks, L. J. J., Wong, D. R., Jong, D. J.

Volltext

Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial von de Rouw, Nikki, Boosman, René J., Burgers, Jacobus A., Huitema, Alwin D. R., Dingemans, Anne-Marie C., Derijks, Hieronymus. J., Burger, David M., Piet, Berber, Hendriks, Lizza E. L., Biesma, Bonne, Pruis, Melinda A., Dumoulin, Daphne W., Croes, Sander, Mathijssen, Ron H. J., van den Heuvel, Michel M., ter Heine, Rob

Volltext

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency von Deben, Debbie S, Derijks, Luc J. J, van den Bosch, Bianca J. C, Creemers, Rob H, van Nunen, Annick, van Bodegraven, Adriaan A, Wong, Dennis R

Volltext

A value proposition for trough level-based anti-TNFα drug dosing von Scharnhorst, V., Schmitz, E.M.H., van de Kerkhof, D., Derijks, L.J.J., Broeren, M.A.C.

Volltext

Patients’ beliefs about medicine are associated with early thiopurine discontinuation in patients with inflammatory bowel diseases von Broekman, Mark M.T.J, Coenen, Marieke J.H, Wanten, Geert J, van Marrewijk, Corine J, Kievit, Wietske, Klungel, Olaf H, Verbeek, André L.M, Wong, Dennis R, Hooymans, Piet M, Guchelaar, Henk-Jan, Scheffer, Hans, Derijks, Luc J.J, Bouvy, Marcel L, de Jong, Dirk J

Volltext

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing von Broekman, Mark M T J, Coenen, Marieke J H, van Marrewijk, Corine J, Wanten, Geert J A, Wong, Dennis R, Verbeek, Andre L M, Klungel, Olaf H, Hooymans, Piet M, Guchelaar, Henk-Jan, Scheffer, Hans, Derijks, Luc J J, de Jong, Dirk J

Volltext

Therapeutic drug monitoring (TDM) as a tool in the switch from infliximab innovator to biosimilar in rheumatic patients: results of a 12-month observational prospective cohort stud... von Schmitz, E. M. H., Benoy - De Keuster, S., Meier, A. J. L., Scharnhorst, V., Traksel, R. A. M., Broeren, M. A. C., Derijks, L. J. J.

Volltext